StockNews.AI
GMED
StockNews.AI
78 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. – GMED

1. Pomerantz LLP investigates securities fraud claims against Globus Medical, Inc. 2. Globus reported disappointing Q1 results, missing EPS and revenue estimates. 3. Stock price plummeted by nearly 23% following negative financial news. 4. The firm's investigation could lead to significant legal repercussions for Globus. 5. Investors are encouraged to join the class action lawsuit.

4m saved
Insight
Article

FAQ

Why Very Bearish?

Globus's significant earnings miss and stock drop suggest investor loss of confidence, similar to past scandals affecting stock prices.

How important is it?

The ongoing investigation and significant stock drop indicate high potential impact on GMED's value and investor sentiment.

Why Short Term?

Immediate legal investigations and market sentiment could disrupt stock performance quickly, as seen in similar cases.

Related Companies

MDTZBHSYKSNN
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Globus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On May 8, 2025, Globus issued a press release reporting its financial results for the first quarter of 2025. Among other items, Globus reported non-GAAP earnings per share of $0.68, missing consensus estimates by $0.06, and revenue of $598.12 million, missing consensus estimates by $27.78 million and representing a 1.4% year-over-year decline. Globus’s President and Chief Executive Officer said that the Company’s “first quarter results were impacted by softer Enabling Technology deal closures, temporary integration related supply chain disruption, and timing of international distributor orders[.]”  On this news, Globus’s stock price fell $16.64 per share, or 22.96%, to close at $55.82 per share on May 9, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News